Analysts think ANGO stock price could increase by 81%
May 06, 2025, 11:26 AM
21.75%
What does ANGO do
AngioDynamics, headquartered in Latham, New York, develops and sells medical devices for vascular access, oncology, and peripheral vascular disease, focusing on minimally invasive procedures. The company went public on May 27, 2004.
5 analysts think ANGO stock price will increase by 81.13%. The current median analyst target is $16.32 compared to a current stock price of $9.01. The lowest analysts target is $15.15 and the highest analyst target is $16.80.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
